OLMA (STOCKS)
Olema Pharmaceuticals, Inc. Common Stock
$23.300000
-0.350000 (-1.48%)
Prev close: $23.650000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sean P. Bohen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,869.75M
- Employees
- 117
- P/E (TTM)
- -13.11
- P/B (TTM)
- 5.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.49 | $-0.49 | +0.0033 | +0.67% |
|
Jun 2025 (Q2)
|
$-0.51 | $-0.38 | -0.1265 | -32.99% |
|
Mar 2025 (Q1)
|
$-0.36 | $-0.52 | +0.1602 | +30.80% |
|
Dec 2024 (Q4)
|
$-0.51 | $-0.65 | +0.1428 | +21.88% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $15.43M |
| Operating Expenses | $165.38M |
| Research and Development | $146.78M |
| Other Operating Expenses | $18.61M |
| Operating Income/Loss | -$165.38M |
| Income/Loss From Continuing Operations After Tax | -$149.96M |
| Income/Loss From Continuing Operations Before Tax | -$149.96M |
| Net Income/Loss | -$149.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$149.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$149.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.76 |
| Diluted Earnings Per Share | -$1.76 |
| Basic Average Shares | 262,205,311 |
| Diluted Average Shares | 262,205,311 |
| Assets | $352.45M |
| Current Assets | $334.33M |
| Cash | $329.00M |
| Other Current Assets | $5.33M |
| Noncurrent Assets | $18.12M |
| Fixed Assets | $486.00K |
| Other Non-current Assets | $17.64M |
| Liabilities | $44.97M |
| Current Liabilities | $41.66M |
| Accounts Payable | $3.47M |
| Wages | $406.00K |
| Other Current Liabilities | $37.78M |
| Noncurrent Liabilities | $3.31M |
| Equity | $307.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $307.49M |
| Liabilities And Equity | $352.45M |
| Net Cash Flow From Operating Activities | -$134.67M |
| Net Cash Flow From Operating Activities, Continuing | -$134.67M |
| Net Cash Flow From Investing Activities | -$108.00M |
| Net Cash Flow From Investing Activities, Continuing | -$108.00M |
| Net Cash Flow From Financing Activities | $242.05M |
| Net Cash Flow From Financing Activities, Continuing | $242.05M |
| Net Cash Flow | -$628.00K |
| Net Cash Flow, Continuing | -$628.00K |
| Comprehensive Income/Loss | -$149.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$149.90M |
| Other Comprehensive Income/Loss | -$42.16M |